1887

Abstract

Introduction. Osteoarthritis (OA) is a common cause of knee pain in older adults. OA is primarily caused by deterioration of cartilage in the knee, which decreases the ability of synovial fluid to absorb shock and increases the opportunity for bones of the joint to rub together. Hylan G-F 20 (Synvisc-One) is a compound that can be injected directly into the knee to help combat the pain associated with OA by lubricating and cushioning the joint.

Case presentation. A 92-year-old male reported to his primary care provider with complaints of pain due to OA. An ultrasound-guided injection of Hylan G-F 20 was administered without complication; however, the patient presented to an emergency department approximately 10 h after the injection complaining of stabbing pain and swelling in the same knee. Specimens submitted for culture 12 h post-injection yielded a Methylobacterium spp. that was identified following biochemical testing, MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) MS analysis and bacterial sequencing. Interestingly, symptoms began to subside following aspiration of synovial fluid, and new cultures of synovial fluid collected 24 h post-Hylan G-F 20 injection were negative for the presence of Methylobacterium . The patient’s knee returned to baseline with diminished pain due to OA approximately 1 week after the initial injection without antibiotic treatment.

Conclusion. We report short-term complications following treatment of OA with a Methylobacterium -contaminated lot of Hylan G-F 20.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005173
2019-01-29
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/6/2/jmmcr005173.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005173&mimeType=html&fmt=ahah

References

  1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58:15–25 [View Article][PubMed]
    [Google Scholar]
  2. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012; 64:1697–1707 [View Article][PubMed]
    [Google Scholar]
  3. Felson DT. Osteoarthritis of the knee. N Engl J Med Overseas Ed 2006; 354:841–848 [View Article]
    [Google Scholar]
  4. Sanofi Genzyme Synvisc One Prescribing Information. Cambridge, MA:: Sanofi Genzyme;; 2016 http://products.sanofi.us/synviscone/synviscone.html [accessed 23 March 2018]
    [Google Scholar]
  5. Liu JW, Wu JJ, Chen HM, Huang AH, Ko WC et al. Methylobacterium mesophilicum synovitis in an alcoholic. Clin Infect Dis 1997; 24:1008–1009 [View Article][PubMed]
    [Google Scholar]
  6. Kovaleva J, Degener JE, van der Mei HC. Methylobacterium and its role in health care-associated infection. J Clin Microbiol 2014; 52:1317–1321 [View Article][PubMed]
    [Google Scholar]
  7. American Society for Microbiology ClinMicroNet: A Closed Listserv discussion Group for Doctoral-Level Microbiology Laboratory Directors Washington, DC: American Society for Microbiology; 2016 www.asm.org/index.php/subscriptions-listservs [accessed 23 March 2018]
    [Google Scholar]
  8. Centers for Disease Control and Prevention Atlanta, GA. MicrobeNet 2017 www.cdc.gov/microbenet/index.html [accessed 23 March 2018]
  9. Brown MA, Greene JN, Sandin RL, Hiemenz JW, Sinnott JT. Methylobacterium bacteremia after infusion of contaminated autologous bone marrow. Clin Infect Dis 1996; 23:1191–1192 [View Article][PubMed]
    [Google Scholar]
  10. de Cal M, Cazzavillan S, Cruz D, Nalesso F, Brendolan A et al. Methylobacterium radiotolerans bacteremia in hemodialysis patients. G Ital Nefrol 2009; 26:616–620 (in Italian)[PubMed]
    [Google Scholar]
  11. Engler C, Norton R. Recurrent Methylobacterium mesophilicum sepsis associated with haemodialysis. Pathology 2001; 33:536–537 [View Article][PubMed]
    [Google Scholar]
  12. Fernandez M, Dreyer Z, Hockenberry-Eaton M, Baker CJ. Methylobacterium mesophilica as a cause of persistent bacteremia in a child with lymphoma. Pediatr Infect Dis J 1997; 16:1007–1008 [View Article][PubMed]
    [Google Scholar]
  13. Kaye KM, Macone A, Kazanjian PH. Catheter infection caused by Methylobacterium in immunocompromised hosts: report of three cases and review of the literature. Clin Infect Dis 1992; 14:1010–1014 [View Article][PubMed]
    [Google Scholar]
  14. Rutherford PC, Narkowicz JE, Wood CJ, Peel MM. Peritonitis caused by Pseudomonas mesophilica in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol 1988; 26:2441–2443[PubMed]
    [Google Scholar]
  15. Sanders JW, Martin JW, Hooke M, Hooke J. Methylobacterium mesophilicum infection: case report and literature review of an unusual opportunistic pathogen. Clin Infect Dis 2000; 30:936–938 [View Article][PubMed]
    [Google Scholar]
  16. Strazzi SR, Baccard M, Puppin D, Plancke L, Morel P et al. Pseudomonas mesophilica cutaneous infection in an immunocompetent patient. Arch Dermatol 1992; 128:273–274 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005173
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005173
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error